Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Stryker by Year
Stryker — U.S. FDA 510(k) Device Clearances (clearances)
Stryker Stryker: 30 in FY2025, down 21.1% from a year earlier.
Latest, FY2025
30
Period ended Dec 31, 2025
Change on a year earlier
-21.1%
38 in FY2024
History
12 years
Since FY2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker
Where the FY2025 figure comes from
Source: U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Reported in U.S. FDA openFDA API (Monthly through 2026-09 & Quarterly through FY2026Q3).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up stryker
- U.S. MedTech Industry Total — FDA 510(k) Clearances (clearances)3,225 · FY2025
- Stryker — U.S. FDA Premarket Approvals (PMA & Supplements, approvals)7 · FY2025
- U.S. MedTech Industry Total — FDA PMA Approvals (approvals)2,222 · FY2025
- Stryker — openFDA Device Recall Events (events)40 · FY2025
- Stryker — openFDA Enforcement Reports (reports)40 · FY2025
- Stryker — FDA MAUDE Adverse Event Reports Total (reports)10,367 · FY2025
Cite this data
StockData. (2026). Stryker Stryker, annual FY2014–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ext-fda-510k
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.